Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,173 papers from all fields of science
Search
Sign In
Create Free Account
Ge 132
Known as:
Ge-132
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
proxigermanium
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Induction of aminolevulinic acid synthase gene expression and enhancement of metabolite, protoporphyrin IX, excretion by organic germanium.
Takashi Nakamura
,
M. Saito
,
Yasuhiro Shimada
,
H. Fukaya
,
Y. Shida
,
Y. Tokuji
European Journal of Pharmacology
2011
Corpus ID: 9530678
2009
2009
Comparison of organic and inorganic germanium compounds in cellular radiosensitivity and preparation of germanium nanoparticles as a radiosensitizer
Ming-Hsing Lin
,
Tzu-Sheng Hsu
,
Pei-Ming Yang
,
M. Tsai
,
T. Perng
,
Lih-Yuan Lin
International Journal of Radiation Biology
2009
Corpus ID: 20539373
Purpose: The aim of this work is to compare the radiosensitizing effect between organic and inorganic germanium compounds and to…
Expand
1994
1994
Effects of Ge-132 on oxygen free radicals and the lipid peroxidation induced by hydroxyl free radical in vitro
Z. Hua
1994
Corpus ID: 86945468
The effects of Ge-132 on oxygen free radicals and hydroxyl free radical induced rat liver homogenate lipid peroxidation in vitro…
Expand
1994
1994
Multidisciplinary treatment of head and neck cancer using BCG, OK‐432, and GE‐132 as biologic response modifiers
H. Fukazawa
,
Y. Ohashi
,
+4 authors
Toshihisa Sato
Head and Neck
1994
Corpus ID: 240914
Since 1979, we have performed multidisciplinary treatment using intensive immunotherapy with biologic response modifiers (BRM) in…
Expand
1993
1993
Effects of 2-carboxythylgerumanium sesquioxide (Ge-132) as an immunological modifier of post-surgical immunosuppression in dogs.
Y. Nakada
,
T. Kosaka
,
M. Kuwabara
,
S. Tanaka
,
K. Sato
,
F. Koide
Journal of Veterinary Medical Science
1993
Corpus ID: 20473090
The effect of 2-carboxythylgerumanium sesquioxide (Ge-132) as an interferon-gamma (IFN-gamma) inducer on post-surgical…
Expand
Review
1987
Review
1987
Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review).
R. Brutkiewicz
,
F. Suzuki
In Vivo
1987
Corpus ID: 29110681
The biological activities and antitumor mechanism of an immunopotentiator, Ge-132, is reviewed herein. Ge-132 exhibited antitumor…
Expand
1985
1985
Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
F. Suzuki
,
R. Brutkiewicz
,
R. Pollard
Anticancer Research
1985
Corpus ID: 27300151
The purpose of this study was to investigate the effective mechanisms of Ge-132, an organogermanium compound with…
Expand
1985
1985
Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
Fujio Suzuki
,
R. Brutkiewicz
,
Richard B. Pollard
British Journal of Cancer
1985
Corpus ID: 9359708
Sera from C57Bl/6 mice treated orally with Ge-132 exhibited antitumour activity against Ehrlich (allogeneic) and RL male 1…
Expand
1985
1985
[Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
F. Suzuki
Gan to kagaku ryoho. Cancer & chemotherapy
1985
Corpus ID: 40521350
The antitumor activity of Ge-132 against a variety of allogeneic and syngeneic murine ascites tumors was first evaluated. The…
Expand
1984
1984
Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132.
F. Suzuki
,
R. Pollard
Journal of Interferon Research
1984
Corpus ID: 28508457
As reported previously, gamma interferon (IFN-gamma) production was selectively decreased in thermally injured mice (TI-Mice) and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE